ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab

NCT07320326 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

159

Enrollment

OTHER

Sponsor class

Conditions

TCE-RRMM

Interventions

DRUG: Elranatamab

Sponsor

Peking University People's Hospital

Collaborators

[object Object]